How A Biopharma Founding CEO Weighed Going Back To The Office
Source: Life Science Leader
In this executive virtual roundtable (EVR) component, James Mackay, PhD, founder, president, and CEO of Aristea Therapeutics, a clinical-stage drug development company headquartered in San Diego, CA, shares how he went about assessing his team for interest in returning to in-office operations after 18 (and counting) months of working remotely. Joining the conversation are Scott Nogi, VP of business operations for Abeona Therapeutics, and Britt Byers, SVP of human resources for Kyowa Kirin North America.
This website uses cookies to ensure you get the best experience on our website. Learn more